Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -198,566.00 |
| Dec 31, 2023 | -112,661.00 |
| Sep 30, 2023 | 21,089.00 |
| Jun 30, 2023 | 3,186.00 |
| Mar 31, 2023 | -42,082.00 |
| Dec 31, 2022 | -1.01 Mn |
| Sep 30, 2022 | -293,462.00 |
| Jun 30, 2022 | -682,773.00 |
| Mar 31, 2022 | -3,139.00 |
| Dec 31, 2021 | 147,016.00 |
| Sep 30, 2021 | -18,968.00 |
| Jun 30, 2021 | 406,374.00 |
| Mar 31, 2021 | -83,841.00 |
| Dec 31, 2020 | 42,627.00 |
| Sep 30, 2020 | -115,003.00 |
| Jun 30, 2020 | 28,858.00 |
| Mar 31, 2020 | -203,422.00 |
| Dec 31, 2019 | 16,779.00 |
| Sep 30, 2019 | 39,555.00 |
| Jun 30, 2019 | 35,599.00 |